Compounding Hearings Are First Step In Creating Active Legislative Ingredients
This article was originally published in The Pink Sheet Daily
Executive Summary
Congress will explore causes and potential policy solutions to the meningitis outbreak at the New England Compounding Center in back-to-back hearings, but any legislation increasing FDA regulatory authority faces a long road.